NARDIL (phenelzine sulfate) shortage in Canada: supply disruption
In plain language
This recall involves NARDIL (phenelzine sulfate) tablets sold in Canada. It's being recalled because of a global shortage, leading to intermittent supply. Patients should consult their healthcare professional to discuss alternative treatments and safe discontinuation.
What to do
- Consult your healthcare professional as soon as possible.
- Discuss alternative treatment options.
- Do not stop taking NARDIL abruptly without medical advice.
- Monitor for withdrawal symptoms if discontinuing treatment.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
NARDIL, Phenelzine Sulfate Tablets USP, 15 mg
Model: DIN 00476552
Why this matters
Serious withdrawal symptoms if discontinued abruptly
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the model number
Model numbers are typically on the product label or packaging.
Affected models: DIN 00476552
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Serious withdrawal symptoms if discontinued abruptly
What should consumers do?
Consult your healthcare professional as soon as possible. Discuss alternative treatment options. Do not stop taking NARDIL abruptly without medical advice. Monitor for withdrawal symptoms if discontinuing treatment.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Serious withdrawal symptoms if discontinued abruptly
When was this product recalled?
This product was recalled on June 24, 2020.
Is the NARDIL brand affected by this recall?
Yes, NARDIL products are affected by this recall. This recall involves NARDIL (phenelzine sulfate) tablets sold in Canada. It's being recalled because of a global shortage, leading to intermittent supply. Patients should consult their healthcare professional to discuss alternative treatments and safe discontinuation.